Kanya Rajangam

Companies

• Turnstone Biologics Corp.Board member Jul 20, 2023 to now¹
• Senti Biosciences Holdings, Inc.Chief Medical & Devt. Officer Jul 15, 2022 to now²
• Nkarta Therapeutics (United States)Chief Medical Officer Jul 9, 2020 to Jan 19, 2022³

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• SBSenti Biosciences Holdings, Inc. SNTI107,843 shares⁴$23.9K at $0.22Mar 9, 2026
• NTNkarta Therapeutics (United States) NKTX12,800 shares⁵$22.8K at $1.78Jan 14, 2022

As of each latest filing. The line shows shares held over time.

Recent filings

• Mar 9, 2026Shares withheld for tax 10,757 shares of Senti Biosciences Holdings, Inc.⁴
• Feb 2, 2026Shares withheld for tax 1,384 shares of Senti Biosciences Holdings, Inc.⁶
• Mar 10, 2025Converted 33,000 shares at $2.25 of Senti Biosciences Holdings, Inc.⁷
• Mar 7, 2025Granted 78,363 shares of Senti Biosciences Holdings, Inc.⁸
• Feb 6, 2025Sold 182 shares at $4.37 of Senti Biosciences Holdings, Inc.⁹
• Feb 4, 2025Sold 1,297 shares at $4.07 of Senti Biosciences Holdings, Inc.⁹
• Feb 1, 2024Granted 101,000 shares of Senti Biosciences Holdings, Inc.¹⁰
• Jan 14, 2022Granted 12,800 shares of Nkarta Therapeutics (United States)⁵